Skip to main content
. 2020 Apr 15;8:e8909. doi: 10.7717/peerj.8909

Figure 1. LOC100506178 is increased in BMP2-induced osteogenic differentiation of hBMSCs.

Figure 1

(A, B) Alizarin Red S Staining was performing on day 28 of osteoblast differentiation. (C) To quantify the amount of alizarin red staining in different groups, ∗∗∗p < 0.001. (D) Quantitative evaluation of the osteogenic differentiation capacity using alkaline phosphatase (ALP) activity assay, ∗∗∗p < 0.001. (E) The expression levels of RUNX2, Osx and ALP mRNA were examined by qPCR, ∗∗∗p < 0.001. (F) qPCR results also showed that the expression of LOC100506178 was significantly up-regulated in BMP2 stimulated hBMSCs, ∗∗∗p < 0.001.